Sergliflozin etabonate T28757
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.
CAS nr:
408504-26-7
Purity:
98%
Molecular Weight:
448,46
SMILES:
O[C@H]([C@H]([C@@H]([C@@H](COC(OCC)=O)O1)O)O)[C@@H]1OC2=CC=CC=C2CC3=CC=C(OC)C=C3
Formula:
C23H28O9
Pathway:
Target:
